Beijing Beilu Pharmaceutical Cash Flow Reinvestment Rate
Beijing Beilu Pharmaceutical cash flow reinvestment rate. Beijing Beilu Pharmaceutical (300016) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting CN¥57.96 Million (capex CN¥57.96 Million ) from operating cash flow of CN¥74.66 Million. See 300016 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Beilu Pharmaceutical (2006–2024)
Cash flow reinvestment rate of Beijing Beilu Pharmaceutical from 2006 to 2024. Historical reinvestment intensity for Beijing Beilu Pharmaceutical across 18 annual periods. Explore cash flow to debt ratio of Beijing Beilu Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Beijing Beilu Pharmaceutical Cash Flow Reinvestment Rate by Year (2006–2024)
Beijing Beilu Pharmaceutical cash flow reinvestment rate by year from 2006 to 2024. Year-by-year capital reinvestment analysis for Beijing Beilu Pharmaceutical. For the full cash flow conversion analysis, see 300016 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥115.95 Million | CN¥163.02 Million | CN¥101.39 Million | ▼ -83.9% |
| 2023 | 4.43x | CN¥258.93 Million | CN¥58.46 Million | CN¥144.61 Million | ▲ +182.3% |
| 2022 | 1.57x | CN¥200.55 Million | CN¥127.81 Million | CN¥102.78 Million | ▼ -0.8% |
| 2021 | 1.58x | CN¥171.89 Million | CN¥108.73 Million | CN¥147.76 Million | ▲ +55.9% |
| 2020 | 1.01x | CN¥178.50 Million | CN¥176.00 Million | CN¥172.10 Million | ▲ +92.6% |
| 2019 | 0.53x | CN¥82.57 Million | CN¥156.81 Million | CN¥34.99 Million | ▼ -54.0% |
| 2018 | 1.14x | CN¥201.08 Million | CN¥175.75 Million | CN¥54.06 Million | ▲ +58.8% |
| 2017 | 0.72x | CN¥104.44 Million | CN¥144.92 Million | CN¥55.00 Million | ▼ -77.9% |
| 2016 | 3.25x | CN¥247.91 Million | CN¥76.17 Million | CN¥44.21 Million | ▲ +259.3% |
| 2015 | 0.91x | CN¥73.23 Million | CN¥80.85 Million | CN¥69.23 Million | ▼ -11.3% |
| 2014 | 1.02x | CN¥42.99 Million | CN¥42.11 Million | CN¥42.99 Million | ▲ +19.0% |
| 2013 | 0.86x | CN¥35.48 Million | CN¥41.37 Million | CN¥35.48 Million | ▼ -69.1% |
| 2012 | 2.78x | CN¥63.47 Million | CN¥22.86 Million | CN¥63.47 Million | ▲ +298.4% |
| 2011 | 0.70x | CN¥31.87 Million | CN¥45.73 Million | CN¥31.87 Million | ▼ -49.5% |
| 2010 | 1.38x | CN¥51.77 Million | CN¥37.51 Million | CN¥51.77 Million | ▲ +1403.5% |
| 2009 | 0.09x | CN¥5.32 Million | CN¥57.91 Million | CN¥5.32 Million | ▲ +393.1% |
| 2007 | 0.02x | CN¥228.50K | CN¥12.28 Million | CN¥228.50K | ▼ -75.7% |
| 2006 | 0.08x | CN¥1.51 Million | CN¥19.65 Million | CN¥1.51 Million | — |